Case Study: Fortune 500 Biopharmaceutical Company achieves reduced attack surface and strengthened cyber resilience with SafeBreach

SafeBreach Makes Mock Scenario Training Real for Fortune 500 Biopharmaceutical Company

Fortune 500 Biopharmaceutical Company faced a credential-theft breach when an insecure URL allowed interception of authentication tokens, and found traditional security testing tools unable to expose the misconfigurations that led to the incident. To validate endpoint and perimeter controls and test their platform against real attacks, the customer engaged SafeBreach and its breach-and-attack simulation platform.

SafeBreach ran MITRE ATT&CK–based simulations, lateral movement scenarios and red/blue exercises to validate endpoint protections, stress-test platform defenses, and inspect all layers of the network border. The SafeBreach engagements identified firewall and configuration gaps, reduced the attack surface, strengthened overall cyber resiliency, and secured the network perimeter—improving security performance and reducing the potential malware blast radius.